Vivo Bio Tech Ltd Share Price

BiotechnologyNSE
₹16.01
+1.69+11.80% (1D)
As on 20 Nov 2026 at 15:55
As of 20 Nov 2026 at 15:55, Vivo Bio Tech Ltd is trading at ₹16.01. The 52-week range stands at ₹12.00–₹34.20, with a market cap of ₹34.99 crore. At a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

VIVOBIOT Price Chart

Market Cap
₹34.99 Cr
PE Ratio
—
ROCE
5.40%

Vivo Bio Tech Ltd Performance

Vivo Bio Tech Ltd Fundamentals

Know More
Market Cap₹34.99 Cr
ROE-3.54%
P/E Ratio (TTM)—
EPS (TTM)—
P/B Ratio0.38
Dividend Yield0.00%
Industry P/E91.72
Book Value₹41.66
Debt to Equity0.85
Face Value₹10

Vivo Bio Tech Ltd Shareholding Pattern

Know More
Promoter22.5%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0%
Public77.5%

Vivo Bio Tech Ltd Financial Statements

Know More
No data for this view.

Vivo Bio Tech Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Vivo Bio Tech

Vivo Bio Tech Limited, established on 12 February 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies, Genotoxicity screening, Analytical services etc. The Company has pioneered as a primary provider of SPF lab animals in India. It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences. The Company serves as an authorized distributor of lab animal diets from Special Diets Services (UK) in India. Their comprehensive services span a wide array of preclinical toxicology disciplines, encompassing In-vitro and In-vivo studies, analytical chemistry studies, bioanalytical studies, and physico-chemical studies. Vivo Bio has partnered with Taconic Biosciences for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents. The Company partnered Cyagen Biosciences to access genomic technologies in 2016. It commenced breeding and distribution of SPF guinea pigs in 2017. The Company acquired 100% shareholding in M/s. Donakanti Consulting Services Private Ltd on 17 April, 2019. It received ISO 9001:2015 Certification for Quality Management System. The Company completed NGCMA - OECD GLP Surveillance and Scope Extension with the introduction of inhalational studies in 2019. The Company transformed from an animal breeding and distributing company into a full service CRO with interest in In-vitro, In-vivo, EcoTox, Analytical, Bio -Analytical and Physchem, ADME and PK-PD studies in 2021-22. The canine/large-animal platform became operational in December 2025. In FY 2026, the Company expanded the toxicology and analytical chemistry infrastructure across multiple specialised domains. It Initiated dog GLP toxicology studies for USA clients. It enhanced bioanalytical capacity with four high-performance LC-MS/MS systems to support small- and large molecule analysis.

Parent Organisation—
Founded1987
Managing Director—
NSE SymbolVIVOBIOT

Vivo Bio Tech Ltd Resistance and Support levels

R316.69R215.95R115.49S114.01S213.55S312.8116.01

Vivo Bio Tech Ltd Technicals

Current Price
₹16.01 ₹1.69 (+11.80%)
Bearish
4
Bullish
8
  • 20 Day7.2%
  • 50 Day1.3%
  • 100 Day1.1%
  • 200 Day1.1%

Vivo Bio Tech Ltd Latest News

View More
07 OCT 2026 | Wednesday
Vivo Bio Tech confirms compliance with SEBI regulations via Aarthi Consultants
30 SEPT 2026 | Wednesday
Vivo Bio Tech shareholders approved financials and re-appointed directors at AGM on September 30, 2026
25 SEPT 2026 | Friday
Vivo Bio Tech closes trading window for insiders ahead of Q2 financial results
22 AUG 2026 | Saturday
Vivo Bio Tech’s board re-appointed directors for five-year terms, pending shareholder approval
22 AUG 2026 | Saturday
Vivo Bio Tech re-appoints Kompella and Alangudi as Whole-Time Directors for five years
08 JUL 2026 | Wednesday
Vivo Bio Tech to table results
28 MAY 2026 | Thursday
Vivo Bio Tech postpones board meeting
26 MAY 2026 | Tuesday
Vivo Bio Tech to hold board meeting

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Vivo Bio Tech Ltd is ₹16.01 as of 20 Nov 2026 at 15:55.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now